PUBLIC CONTRACT · 2012
Aquisição de Natalizumab 20 mg/ml sol inj Fr 15 ml IV
- Contract value
- €5,445.00
- Signed on
- 31 October 2012
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 615231PUBLISHED SUBJECT
Aquisição de Natalizumab 20 mg/ml sol inj Fr 15 ml IV
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Faro, Portimão
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BIOGEN IDEC PORTUGAL · Tax ID 506415740
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €5,445.00
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 15 November 2012
- Award date
- 31 October 2012
- Signing date
- 31 October 2012
- Performance period
- 2 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33652000-5 - Antineoplásicos e imunomoduladores
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 529636
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.